RYVLX | RYWVX | RYVLX / RYWVX | |
Total Expense Ratio | 1.90 | 1.85 | 103% |
Annual Report Gross Expense Ratio | 2.01 | 1.93 | 104% |
Fund Existence | 21 years | 14 years | - |
Gain YTD | -24.765 | -5.010 | 494% |
Front Load | 5% | N/A | - |
Min. Initial Investment | 2500 | 2500 | 100% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 635M | 2.99M | 21,273% |
Annual Yield % from dividends | 0.00 | 3.43 | - |
Returns for 1 year | -12.35 | -3.74 | 330% |
Returns for 3 years | 21.80 | -9.05 | -241% |
Returns for 5 years | 165.36 | 22.20 | 745% |
Returns for 10 years | 444.88 | -14.73 | -3,020% |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
FIJYX | 25.47 | 0.85 | +3.45% |
Fidelity Advisor Biotechnology Z | |||
ESMAX | 14.60 | 0.26 | +1.81% |
Invesco EQV Euro Small Company A | |||
JHISX | 11.39 | 0.18 | +1.61% |
Janus Henderson VIT Global Sust Eq Ins | |||
FEQTX | 27.03 | 0.41 | +1.54% |
Fidelity Equity Dividend Income | |||
MNBWX | 18.79 | 0.19 | +1.02% |
Manning & Napier Pro-Blend Extnd Term W |